Back to search

Aristotle University Of Thessaloniki (AUTH)

Η σχέση του πηκτικού προφίλ του ασθενούς με την έκβαση της ενδαγγειακής θεραπείας ανευρύσματος κοιλιακής αορτής

Abstract

dc:description

Background: The aim of this study was to investigate 1) the potential association between perioperative fibrinogen levels and outcome in patients undergoing elective endovascular repair (EVAR) of abdominal aortic aneurysms (AAAs), and 2) whether the transfusion of two units of fresh frozen plasma (FFP) immediately post-aneurysm exclusion has any effect on the perioperative fibrinogen levels and the outcome of patients undergoing elective EVAR. Methods: First, a retrospective analysis was undertaken of consecutive patients with an intact AAA who underwent elective EVAR with the bifurcated Endurant-II (MEDTRONIC) stent-graft in our unit between December 2012 and September 2016. As a routine, all patients received two units of FFP intraoperatively. Preoperative and 24-hour postoperative fibrinogen levels and the perioperative change in fibrinogen Δfib (defined as 24-hour postoperative minus preoperative fibrinogen) were recorded and potential associations with outcome were tested. Second, a prospective comparative analysis was undertaken of consecutive patients who underwent elective EVAR with the bifurcated Endurant-II stent-graft in two vascular units. The recruitment period was between October 2016 and February 2020 in our unit and between January 2014 and October 2018 in the second unit. Our unit has a routine policy of administering two units of FFP immediately upon aneurysm exclusion (FFP group), whereas the second unit has no such policy (control group). Serum fibrinogen levels were measured on admission and 24 hours post-EVAR and the perioperative change in fibrinogen Δfib was calculated. The two groups were compared with regards to the perioperative fibrinogen levels (preoperative, 24-hour postoperative, and Δfib) and the outcome (endoleaks, reinterventions, major adverse cardiovascular events, death) during follow-up. Results: 94 patients (91 males, mean age 71.8 ± 8.0 years) with an intact AAA were included in the retrospective study. The technical success was 98% (2 failures: 1 type Ia endoleak on completion angiography, 1 lower limb ischemia immediately postoperatively requiring femoral endarterectomy). There was one death during the first 30 days due to myocardial infarction (1%). Another patient died 15 months post-procedure from cardiac causes. During the existing follow-up (mean 14.8 ± 14.3 months), 14 patients (15%) developed an endoleak (4 type Ia, 10 type II), 6 patients (6.3%) had lower limb ischemia/endograft limb occlusion and 10 (10.6%) required reintervention. Compared to the preoperative values, no significant change occurred with regards to the fibrinogen levels 24 hours postprocedure (mean preoperative fibrinogen 360 ± 101 mg/dl vs 24-hour postoperative fibrinogen 349 ± 105 mg/dl, p=0.1). Neither preoperative nor 24-hour postoperative fibrinogen levels were significantly associated with the development of endoleaks, lower limb ischemia or reinterventions. However, the difference in fibrinogen levels Δfib was significantly higher in patients with endoleaks (median -65 mg/dl vs 15mg/dl, p=0.04). In the prospective comparative study, a total of 70 patients (41 in the FFP group, 29 controls) were examined. There were 68 men, the mean age was 70 ± 7 years and the maximum AAA diameter was 63.3 ± 13.8 mm. During the follow-up (34 ± 19 months), a total of 6 endoleaks were recorded (2 type Ia, 3 type Ib and 1 type II). Mean preoperative fibrinogen, 24-hour postoperative fibrinogen and Δfib was 391.1 ± 92.8 mg/dl, 367.7 ± 97.8 mg/dl and -23.5 ± 51.02 mg/dl, respectively. There was a trend for the fibrinogen to fall 24h postprocedure, but this was not statistically significant (p=0.07). There was weak negative association between Δfib and endoleaks (p=0.007, r=-0.29). Compared to controls, the FFP group had a higher 24-hour postoperative fibrinogen (401.8 ± 112.9 mg/dl vs 319.3 ± 34.9 mg/dl, p<0.0001) and a lower Δfib (-3.00 ± 56.01 mg/dl vs -52.48 ± 21.15 mg/dl, p<0.0001). No significant difference was observed between the two groups with regards to endoleaks, reinterventions, major adverse cardiovascular events, or deaths. Conclusions: Perioperative fibrinogen levels may play a role in predicting outcome in elective EVAR patients and appears to be associated, directly or indirectly, with the development of endoleaks. Transfusion of two units of FFP post-aneurysm exclusion prevents a significant drop in plasma fibrinogen 24 hours post-EVAR, but the impact on clinical outcome has yet to be defined. Further studies are needed to investigate these findings and explore future therapeutic implications.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kapetanios, Dimitrios
  • Καπετάνιος, Δημήτριος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48219

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kapetanios, Dimitrios; Καπετάνιος, Δημήτριος. Η σχέση του πηκτικού προφίλ του ασθενούς με την έκβαση της ενδαγγειακής θεραπείας ανευρύσματος κοιλιακής αορτής. Aristotle University Of Thessaloniki (AUTH), 2020. http://hdl.handle.net/10442/hedi/48219